Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.35 (-0.70) | AIM:£3.24 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China

1 items
a070523